U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H28O3
Molecular Weight 376.488
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ESTRADIOL BENZOATE

SMILES

[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]3([H])C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CC[C@@]23[H]

InChI

InChIKey=UYIFTLBWAOGQBI-BZDYCCQFSA-N
InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1

HIDE SMILES / InChI

Molecular Formula C25H28O3
Molecular Weight 376.488
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020375s027lbl.pdf

Estradiol an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In humans, it is produced primarily by the cyclic ovaries and the placenta. It is also produced by the adipose tissue of men and postmenopausal women. The 17-alpha-isomer of estradiol binds weakly to estrogen receptors (receptors, estrogen) and exhibits little estrogenic activity in estrogen-responsive tissues. Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estradiol is used for the treatment of urogenital symptoms associated with post-menopausal atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria). Estradiol is marketed under the brand name Climara (among others), indicated for: the treatment of moderate to severe vasomotor symptoms due to menopause, treatment of symptoms of vulvar and vaginal atrophy due to menopause, treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure and prevention of postmenopausal osteoporosis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P08842
Gene ID: 412.0
Gene Symbol: STS
Target Organism: Homo sapiens (Human)
0.0084 nM [EC50]
1.4 nM [EC50]
19.1 nM [IC50]
0.13 nM [Ki]
0.09 nM [Kd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CLIMARA

Approved Use

Climara is an estrogen indicated for: •Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause •Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause •Treatment of Hypoestrogenism due to Hypogonadism, Castration or Primary Ovarian Failure •Prevention of Postmenopausal Osteoporosis

Launch Date

1974
Preventing
CLIMARA

Approved Use

Climara is an estrogen indicated for: •Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause •Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause •Treatment of Hypoestrogenism due to Hypogonadism, Castration or Primary Ovarian Failure •Prevention of Postmenopausal Osteoporosis

Launch Date

1974
Primary
CLIMARA

Approved Use

Climara is an estrogen indicated for: •Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause •Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause •Treatment of Hypoestrogenism due to Hypogonadism, Castration or Primary Ovarian Failure •Prevention of Postmenopausal Osteoporosis

Launch Date

1974
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
14.7 pg/mL
0.25 mg 1 times / day steady-state, topical
dose: 0.25 mg
route of administration: Topical
experiment type: STEADY-STATE
co-administered:
ESTRADIOL plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: FEMALE
food status: UNKNOWN
92 pg/mL
0.05 mg 1 times / day multiple, topical
dose: 0.05 mg
route of administration: Topical
experiment type: MULTIPLE
co-administered:
ESTRADIOL plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: FEMALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
236 pg × h/mL
0.25 mg 1 times / day steady-state, topical
dose: 0.25 mg
route of administration: Topical
experiment type: STEADY-STATE
co-administered:
ESTRADIOL plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: FEMALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
10 h
0.25 mg 1 times / day steady-state, topical
dose: 0.25 mg
route of administration: Topical
experiment type: STEADY-STATE
co-administered:
ESTRADIOL plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: FEMALE
food status: UNKNOWN
1.75 h
0.05 mg 1 times / day multiple, topical
dose: 0.05 mg
route of administration: Topical
experiment type: MULTIPLE
co-administered:
ESTRADIOL plasma
Homo sapiens
population: UNKNOWN
age: ADULT
sex: FEMALE
food status: UNKNOWN
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG



Drug as perpetrator​

Drug as perpetrator​

Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
minor
minor
minor
minor
minor
minor
no
no
no
no
no
no
no
no
no
yes [Km 7 uM]
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Sulfation of estrone and 17 beta-estradiol in human liver. Catalysis by thermostable phenol sulfotransferase and by dehydroepiandrosterone sulfotransferase.
1992 May-Jun
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
1998 Oct
Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
2000 Apr
Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
2000 Apr 1
Expression of the estrogen-regulated gene Nip2 during rat brain maturation.
2000 Apr-Jun
WISP-2 as a novel estrogen-responsive gene in human breast cancer cells.
2000 Aug 18
Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells.
2000 Dec
High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
2000 Feb 1
Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells.
2000 Feb 25
The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.
2000 Jan 1
Six high-priority organochlorine pesticides, either singly or in combination, are nonestrogenic in transfected HeLa cells.
2000 Mar-Apr
Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes.
2000 May
Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene.
2000 Nov
Female sex steroids: effects upon microglial cell activation.
2000 Nov 1
Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation.
2000 Nov 14
Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells.
2000 Oct
Repression of chick multidrug resistance-associated protein 1 (chMRP1) gene expression by estrogen.
2000 Oct 31
NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1.
2000 Sep
Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer.
2001 Apr 6
Vitellogenin-induced pathology in male summer flounder (Paralichthys dentatus).
2001 Feb
Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results.
2001 Feb
Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells.
2001 Feb 2
Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites.
2001 Feb 9
Increased expression of a novel heat shock protein transcript in the mouse uterus during decidualization and in response to progesterone.
2001 Jan
Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse.
2001 Jan
Pregnancy stimulates secretion of adrenocorticotropin and nitric oxide from peripheral bovine lymphocytes.
2001 Jan
Follicle selection in cattle: role of luteinizing hormone.
2001 Jan
Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats.
2001 Jan
Changes in follicle-stimulating hormone and follicle populations during the ovarian cycle of the common marmoset.
2001 Jan
Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression.
2001 Jan
Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
2001 Jan
Metabolism of estradiol, ethynylestradiol, and moxestrol in rat uterus, vagina, and aorta: influence of sex steroid treatment.
2001 Jan
Sex steroid hormones enhance immune function in male and female Siberian hamsters.
2001 Jan
Rapid and reversible inhibition of brain aromatase activity.
2001 Jan
Oestrogen-induced changes in the synaptology of the monkey (Cercopithecus aethiops) arcuate nucleus during gonadotropin feedback.
2001 Jan
Stimulatory effect of clofibrate and gemfibrozil administration on the formation of fatty acid esters of estradiol by rat liver microsomes.
2001 Jan
Influence of gender and sex hormones on nicotine acute pharmacological effects in mice.
2001 Jan
Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart.
2001 Jan
Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle.
2001 Jan
Dose-response relationships and pharmacokinetics of vitellogenin in rainbow trout after intravascular administration of 17alpha-ethynylestradiol.
2001 Jan
Evaluation of an EIA method for measuring serum levels of the estrogen metabolite 2-hydroxyestrone in adults.
2001 Jan
Estradiol levels in psychotic disorders.
2001 Jan
Neuroprotection by estradiol.
2001 Jan
Effects of heterocyclic amines with mammary gland carcinogenic potential on estrogenic response of uterus in ovariectomized rats.
2001 Jan 10
Reduction of gamma-aminobutyric acid-ergic neurotransmission as a putative mechanism of radiation induced activation of the gonadotropin releasing-hormone-pulse generator leading to precocious puberty in female rats.
2001 Jan 5
Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1.
2001 Mar 2
Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.
2001 Mar 23
Enhanced multispecificity of arabidopsis vacuolar multidrug resistance-associated protein-type ATP-binding cassette transporter, AtMRP2.
2001 Mar 23
Evaluation of Effects of Topical Estradiol Benzoate Application on Cutaneous Wound Healing in Ovariectomized Female Mice.
2016
Changes in Expression of Connexin Isoforms in the Caudal Epididymis of Adult Sprague-Dawley Rats exposed to Estradiol Benzoate or Flutamide at the Neonatal Age.
2016 Sep
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Estradiol benzoate is not approved by the FDA for use in humans in the United States.
Unknown
Route of Administration: Unknown
Estradiol-3-sulfate (E2SO4) infused intracerebroventricularly (icv) significantly increased plasma adrenocorticotropic hormone (ACTH) and cortisol concentrations. All minipumps in the treated fetuses were filled with E2SO4 in the vehicle (water) and minipumps in the control fetuses were filled with vehicle only. These minipumps deliver a constant infusion of 5 μL/h; the concentration of E2SO4 in infusates was therefore 8.33 μg/μL. It was concluded, that E2SO4 had complex actions on the fetal brain, which might involve deconjugation by steroid sulfatase. But that the net result of direct E2SO4 icv infusion was more complex than could be accounted for by infusion of E2 alone.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:16:09 GMT 2023
Edited
by admin
on Fri Dec 15 15:16:09 GMT 2023
Record UNII
1S4CJB5ZGN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ESTRADIOL BENZOATE
EP   GREEN BOOK   INN   MART.   USP   USP-RS   WHO-DD  
INN  
Official Name English
estradiol benzoate [INN]
Common Name English
ESTRADIOL BENZOATE [GREEN BOOK]
Common Name English
ESTRADIOL BENZOATE [MART.]
Common Name English
ESTRADIOL BENZOATE [USP-RS]
Common Name English
OESTRADIOL BENZOATE
Common Name English
ESTRADIOL BENZOATE [USP IMPURITY]
Common Name English
ESTRADIOL 3-BENZOATE [MI]
Common Name English
NSC-9566
Code English
ESTRADIOL BENZOATE [JAN]
Common Name English
Estradiol 3-benzoate
MI  
Common Name English
ESTRADIOL BENZOATE [USP MONOGRAPH]
Common Name English
Estradiol benzoate [WHO-DD]
Common Name English
ESTRADIOL BENZOATE [EP MONOGRAPH]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 522.1940
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
NCI_THESAURUS C478
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
CFR 21 CFR 522.842
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
CFR 21 CFR 522.2478
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID9022998
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
SMS_ID
100000085434
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
RS_ITEM_NUM
1251000
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-043-7
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
EVMPD
SUB07243MIG
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
CAS
50-50-0
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
NSC
9566
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
RXCUI
60661
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY RxNorm
PUBCHEM
222757
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
MESH
C074283
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
FDA UNII
1S4CJB5ZGN
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
MERCK INDEX
m5028
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY Merck Index
DAILYMED
1S4CJB5ZGN
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
ChEMBL
CHEMBL282575
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
INN
405
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
CHEBI
77006
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
DRUG BANK
DB13953
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
NCI_THESAURUS
C29769
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
DRUG CENTRAL
1058
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
WIKIPEDIA
Estradiol benzoate
Created by admin on Fri Dec 15 15:16:09 GMT 2023 , Edited by admin on Fri Dec 15 15:16:09 GMT 2023
PRIMARY
Related Record Type Details
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
BASIS OF STRENGTH->SUBSTANCE
ASSAY (UV)
EP
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (TLC)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 3.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (TLC)
USP
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (TLC)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY